Project Grant R21EB036619
- This $395,695 federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) aims to develop novel multi-modal ultrasound imaging methods for non-invasive, real-time monitoring of tissue healing and early prognosis. The project will investigate new prognostic markers related to vascular and interstitial fluid transport mechanisms to assess...
- This Project Grant award of $502,294 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) is supporting research on engineered biomaterials to promote lymphatic regeneration for the treatment of lymphedema. The primary goal is to integrate advanced biomaterials and targeted delivery of lipid nanoparticles into current lymphedema surgical procedures to enhance lymphangiogenesis and improve treatment outcomes. The research is being conducted by the...
- This $598,134 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development of a novel imaging detector module. The project aims to create an advanced SPECT imaging system that can provide spatial and directional information without rejecting photons, enabling more precise and personalized dosimetry for therapeutic...
- The federal Project Grant award of $491,029 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports the development of a novel bioengineered lymphatic regenerating platform for the treatment of breast cancer-related lymphedema. The platform utilizes an alginate mechacrylate (ALMA) hydrogel coated with an anti-fibrotic small molecule and contains programmable cell therapies to encourage lymphatic vessel regeneration and recruitment. This research...
- This Project Grant award of $306,798 from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) aims to develop an artificial intelligence-based system to accurately identify malignant lymph nodes. The key objectives are to: Create a lymph node segmentation model to enable extraction of radiomic features critical for malignancy classification. Develop both cloud-based and standalone desktop deployment options for the classification model to...
- This $429,114 federal Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) will fund the development and validation of a first-of-its-kind multi-tissue on-a-chip breast-skin platform. The platform will feature integrated blood and lymphatic vasculature to study the spatial and temporal processes of lymphovascular space invasion (LVSI), dermal lymphatic invasion (DLI), and skin metastasis in breast cancer. The central hypothesis is that the cross-talk...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,205,290 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the Massachusetts Eye And Ear Infirmary. The grant supports the development of a fluorescence lifetime-based intraoperative imaging system to enhance visualization and real-time feedback for sarcoma surgeries. The project aims to create new tools that can accurately detect...
- This $613,124 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) will support research and development of a new quantitative phase imaging technology for real-time, noninvasive capillaroscopy. The key innovation is the use of phase imaging meta-sensors (PIMSS) that can simultaneously resolve phase and amplitude contrast in a single...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,161,839 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the University of Wisconsin System for the project "MRI Technology for Greater Efficiency and Improved Value". The overall goal is to design technologies that improve the value of MRI by enhancing efficiency, accessibility, safety, and user experience. Key...
- This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" provides $417,837 to the University of Texas at Austin to develop a new computational framework and specialized antenna arrays to enhance 3D electromagnetic (EM) imaging capabilities. The key products and services to be delivered through this 24-month award include:...
The University of Texas Southwestern Medical Center was awarded a $642,639 Project Grant by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), to develop advanced imaging and analysis tools for lymphoscintigraphy (LSG) in lymphedema. This 3-year project, commencing on September 1, 2025, aims to enhance LSG, the current standard imaging technique for diagnosing lymphedema, in order to guide improved lymphedema care and drive medical innovations. The research focuses on addressing the primary limitations of 2D planar LSG, such as low photon counts and lack of attenuation correction, to produce higher-quality, quantitative images that can better support the diagnosis and treatment of this prevalent condition affecting over 10 million Americans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $642.6k | 8/8/25 |